Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 10
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Variant allele frequency: a decision-making tool in precision oncology?
Boscolo Bielo L, Trapani D, Repetto M, Crimini E, Valenza C, Belli C, Criscitiello C, Marra A, Subbiah V, Curigliano G. Boscolo Bielo L, et al. Among authors: valenza c. Trends Cancer. 2023 Dec;9(12):1058-1068. doi: 10.1016/j.trecan.2023.08.011. Epub 2023 Sep 12. Trends Cancer. 2023. PMID: 37704501 Review.
The immunogram of inflammatory breast cancer.
Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, Curigliano G. Valenza C, et al. Cancer Treat Rev. 2023 Sep;119:102598. doi: 10.1016/j.ctrv.2023.102598. Epub 2023 Jul 8. Cancer Treat Rev. 2023. PMID: 37437342 Review.
Targeting HER2 heterogeneity in breast and gastrointestinal cancers.
Valenza C, Guidi L, Battaiotto E, Trapani D, Sartore Bianchi A, Siena S, Curigliano G. Valenza C, et al. Trends Cancer. 2024 Feb;10(2):113-123. doi: 10.1016/j.trecan.2023.11.001. Epub 2023 Nov 25. Trends Cancer. 2024. PMID: 38008666 Review.
Treatment optimization in early triple negative breast cancer.
Kotteas E, Bielo LB, Valenza C, Santoro C, Koukoutzeli C, Trapani D, Curigliano G. Kotteas E, et al. Among authors: valenza c. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(10):1107-1116. doi: 10.1080/14737140.2023.2268840. Epub 2023 Oct 26. Expert Rev Anticancer Ther. 2023. PMID: 37873652 Review.
New Concepts in Cardio-Oncology.
Zagami P, Nicolò E, Corti C, Valenza C, Curigliano G. Zagami P, et al. Among authors: valenza c. Cancer Treat Res. 2023;188:303-341. doi: 10.1007/978-3-031-33602-7_12. Cancer Treat Res. 2023. PMID: 38175351
Cardiotoxicity of Agents Used in Patients With Breast Cancer.
Zagami P, Trapani D, Nicolò E, Corti C, Valenza C, Criscitiello C, Curigliano G, Carey LA. Zagami P, et al. Among authors: valenza c. JCO Oncol Pract. 2024 Jan;20(1):38-46. doi: 10.1200/OP.23.00494. Epub 2023 Nov 20. JCO Oncol Pract. 2024. PMID: 37983586 Review.
Emerging treatment landscape of non-muscle invasive bladder cancer.
Valenza C, Antonarelli G, Giugliano F, Aurilio G, Verri E, Briganti A, Curigliano G, Necchi A. Valenza C, et al. Expert Opin Biol Ther. 2022 Jun;22(6):717-734. doi: 10.1080/14712598.2022.2082869. Epub 2022 May 31. Expert Opin Biol Ther. 2022. PMID: 35634893 Review.
Biomarkers for Antibody-Drug Conjugates in Solid Tumors.
Katrini J, Boldrini L, Santoro C, Valenza C, Trapani D, Curigliano G. Katrini J, et al. Among authors: valenza c. Mol Cancer Ther. 2024 Apr 2;23(4):436-446. doi: 10.1158/1535-7163.MCT-23-0482. Mol Cancer Ther. 2024. PMID: 38363729 Review.
29 results